Literature DB >> 3472777

Variant Philadelphia translocations in chronic myeloid leukemia.

M De Braekeleer.   

Abstract

Up to the beginning of 1986, some 327 variant Philadelphia translocations were reported in chronic myeloid leukemia. The present study represents an attempt to determine which factors (sex, age, geographic localization, etc.) influence the occurrence and chromosome involvement of these variant Philadelphia (Ph1) translocations. Clinical data indicated that band 9q34 was always rearranged in the variant Ph1 translocations and no difference existed between the hematologic and prognostic features among patients with the standard and the variant translocations. An uneven geographic distribution of the variant Ph1 translocations was found. Whether this was due to populations with different ethnic backgrounds or to environmental factors could not be determined. Twenty-eight bands were shown to be rearranged more frequently than expected (P less than 0.05); 27 of them are known to contain a fragile site and/or an oncogene and/or are rearranged more frequently than expected in other malignancies. The chromosomes involved in these variant Ph1 translocations were found to show a very particular geographic distribution, which cannot be explained at present.

Entities:  

Mesh:

Year:  1987        PMID: 3472777     DOI: 10.1159/000132374

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN: 0301-0171


  7 in total

1.  Molecular cloning of the breakpoints of a complex Philadelphia chromosome translocation: identification of a repeated region on chromosome 17.

Authors:  T W McKeithan; L Warshawsky; R Espinosa; M M LeBeau
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

Review 2.  Molecular analysis of the Philadelphia chromosome.

Authors:  A Dobrovic; G B Peters; J H Ford
Journal:  Chromosoma       Date:  1991-09       Impact factor: 4.316

3.  Aberrant breakpoints in chronic myelogenous leukemia; oncogenes and fragile sites.

Authors:  M De Braekeleer
Journal:  Hum Genet       Date:  1988-02       Impact factor: 4.132

4.  Successful treatment with nilotinib after imatinib failure in a CML patient with a four-way Ph chromosome translocation and point mutations in BCR/ABL gene.

Authors:  Masaya Okada; Atsushi Satake; Katsuji Kaida; Kyoko Taniguchi; Satoshi Yoshihara; Kazuhiro Ikegame; Hiroya Tamaki; Toshihiro Soma; Yoshihiro Fujimori; Hiroyasu Ogawa
Journal:  Int J Hematol       Date:  2011-02-01       Impact factor: 2.490

5.  [Particular evolution of complex cytogenetic variants of chronic myeloid leukemia treated with imatinib].

Authors:  Salifo Sawadogo; Francis Michel Hien; Rasmané Béogo; Aboubacar Toguyeni; Georges Anicet Ouédraogo
Journal:  Pan Afr Med J       Date:  2013-08-11

Review 6.  RNA-Binding Proteins in Acute Leukemias.

Authors:  Konstantin Schuschel; Matthias Helwig; Stefan Hüttelmaier; Dirk Heckl; Jan-Henning Klusmann; Jessica I Hoell
Journal:  Int J Mol Sci       Date:  2020-05-12       Impact factor: 5.923

7.  New complex chromosomal translocation in chronic myeloid leukaemia: t(9;18;22)(q34;p11;q11).

Authors:  Abdeljabar El Andaloussi; Chrystele Bilhou-Nabera
Journal:  J Biomed Biotechnol       Date:  2007
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.